---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-033285"
form_type: "8-K"
ticker: "ALBT"
cik: "0001630212"
company_name: "Avalon GloboCare Corp."
filed_at: "2023-04-27T23:59:59+00:00"
generated_at: "2026-06-16T09:02:37.617149+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Avalon GloboCare reports LSM 2022 revenue $14.7M, net income $6.3M; 40% interest acquired Feb 2023

## Summary
- LSM FY2022: revenue $14.7M, gross profit $8.1M, net income $6.3M, total operating expense $2.4M.
- Avalon acquired 40% of LSM in Feb 2023; profit-sharing arrangement expected to produce significant future cash flow.
- LSM provides broad diagnostic tests (drug testing, toxicology, pharmacogenetics, etc.) and has completed 600K+ tests since inception.
- CEO cites fragmented lab market as roll-up opportunity to leverage LSM infrastructure for synergies.

## SEC filing metadata
- accession: 0001213900-23-033285
- form_type: 8-K
- ticker: ALBT
- cik: 0001630212
- company_name: Avalon GloboCare Corp.
- filed_at: 2023-04-27T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630212/000121390023033285/0001213900-23-033285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630212/000121390023033285/ea177537-8k_avalon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-033285
- JSON: https://secwatch.observer/filing/0001213900-23-033285.json
- Plain text: https://secwatch.observer/filing/0001213900-23-033285.txt

## Key facts
- Earnings Releases
  Avalon GloboCare Corp. reported the twelve months ended December 31, 2022 results: revenue $14.7 million, net income $6.3 million.
  - Period: the twelve months ended December 31, 2022
  - Revenue: $14.7 million
  - Net income: $6.3 million
  - Result: reported results
  source text: LSM 2022 Financial Highlights · Revenue was $14.7 million · Gross profit was $8.1 million · Total operating expense was $2.4 million · Net income was $6.3 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630212/000121390023033285/0001213900-23-033285-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.